Relativity Healthcare Partners

Relativity Healthcare Partners was founded by Michael Chao, whose father is Allen Chao, founder of Watson Pharmaceuticals. Watson, now part of Teva following a $40.5 billion acquisition of Allergan's generics business, originated as a small California-based generic drug manufacturer. The Chao family's operational experience scaling Watson into a major industry player directly informs Relativity's investment philosophy and its ability to advise portfolio companies on regulatory and commercial pathways.

Relativity's edge lies in the Chao family's direct operational history with Watson Pharmaceuticals, a generics company that grew through aggressive consolidation and manufacturing scale. For portfolio companies, this translates into practical guidance on FDA regulatory strategy, manufacturing process optimization, and potential exit pathways to larger pharmaceutical acquirers. This operator-first lens is reinforced by Alfonso Chang's dual role as CEO of Parsolex, a separate operating entity.